Our therapies in North America are concentrated within the areas of hematology and immunology.
Within hematology, our portfolio also addresses Immune thrombocytopenia (ITP), a rare autoimmune disease affecting platelet production and Cytopenic myelofibrosis, a rare blood disease characterized by scarring of the bone marrow, as well as disruption of the normal production of blood cells
Immunology has been central to our work at Sobi for many years, enabling us to build extensive experience in the field. Our Immunology portfolio addresses auto-inflammatory and auto-immune conditions - serious, disabling or even life-threatening diseases.
Hematology
The area of hematology covers a wide range of conditions, including those involving red and white blood cells, coagulation and platelets, and bone marrow.
Immunology
The field of immunology has long been at the heart of what we do at Sobi, allowing us to gain extensive experience over many years.
Our medicines within rare diseases
Read more how we at Sobi North America work to make
more available medicines that transform the lives of
people with rare and debilitating diseases.